Form 8-K Vitamin Shoppe, Inc. For: Jun 03

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): June 3, 2015

 

 

Vitamin Shoppe, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware		001-34507		11-3664322
(State or Other Jurisdiction of Incorporation or Organization)		(Commission File Number)		(IRS Employer Identification No.)

2101 91st Street

North Bergen, New Jersey 07047

(Addresses of Principal Executive Offices, including Zip Code)

(201) 868-5959

(Registrant’s Telephone Number, Including Area Code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

---

ITEM 5.07

Submission of Matters to a Vote of Security Holders.

On June 3, 2015, Vitamin Shoppe, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). At the Annual Meeting, our stockholders: (a) elected the persons listed below to serve as directors for a term of one year expiring at the 2016 Annual Meeting or until their successors are duly elected and qualified; (b) approved the compensation paid to the Company’s named executive officers; (c) approved the Internal Revenue Code Section 162(m)-Compliant Vitamin Shoppe, Inc. Covered Employee Performance-Based Compensation Plan; and (d) ratified the appointment of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the 2015 fiscal year. Set forth below are the voting results for each of these proposals:

a.

 

Director						For				Against				Abstain
B. Michael Becker							24,613,737				912,096				1,996
John D. Bowlin							25,381,304				144,829				1,696
Catherine E. Buggeln							25,443,061				58,170				26,598
Deborah M. Derby							25,041,007				459,924				26,898
John H. Edmondson							24,554,520				946,376				26,933
David H. Edwab							24,237,412				1,263,484				26,933
Richard L. Markee							25,403,590				97,306				26,933
Richard L. Perkal							25,417,514				83,682				26,633
Beth M. Pritchard							25,378,276				122,955				26,598
Colin Watts							25,455,000				45,896				26,933
Broker Non-Votes			1,189,826

b.

 

For		Against		Abstain		Non-Votes
24,259,182		1,253,582		15,065		1,189,826

c. The Internal Revenue Code Section 162(m)-Compliant Vitamin Shoppe, Inc. Covered Employee Performance-Based Compensation Plan was approved.

 

For		Against		Abstain		Non-Votes
25,028,099		492,226		7,504		1,189,826

 

d.	The proposal to ratify the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the 2015 fiscal year was approved.

 

For		Against		Abstain		Non-Votes
24,919,061		1,784,549		14,045		0

---

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

				Vitamin Shoppe, Inc.
Date: June 5, 2015				By:		/s/ Brenda M. Galgano
				Name:		Brenda M. Galgano
				Title:		Executive Vice President and Chief Financial Officer

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• TabaPay to Acquire the Assets of Synapse Financial Technologies, Inc.
• Avis Budget Group to Announce First Quarter 2024 Results on May 1st
• FluroTech and GS Heli Announce Execution of Definitive Agreement